SGP - Schering-Plough Corp

Profile for ScheringPlough Corp. (SGP)

After Hours: $ 14.35

0.01 (+0.07%)

Volume: 530.84 k

7:51 PM EST Nov 21, 2008

Business Description:
The Company discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, animal health, and consumer.

Address:

2000 Galloping Hill Road, Kenilworth, NJ 07033

Telephone:

(908) 298-4000

Website:

www.schering-plough.com

Facsimile:

(908) 298-7082

Email:

Details

CEO:

Fred Hassan

Employees:

55000

Market Cap:

23.32 b

Issue Type:

Common Stock

Auditor:

Deloitte & Touche LLP

Last Audit:

Unqualified

Indices:

DJ US Pharmaceuticals, Fortune 500 Industrial, Drug Manufacturers - Major, Russell 1000, S&P 1500 Pharmaceuticals Index, S&P 500 Pharmaceuticals Index, S&P 900 Pharmaceuticals Index, S&P Composite

Industry Classifications

Sector:

Healthcare

CIK:

0000310158

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Drug Manufacturers - Major (510)

SIC:

Pharmaceutical Preparations (2834)

Profitability

Management Effectiveness

Gross Margin:

71.80

Return on Equity:

EBIT Margin:

-7.90

Return on Capital:

-10.40

Profit Margin:

-10.20

Return on Assets:

-7.10

Share Statistics

Outstanding:

1.63 b

Float:

1.62 b

Short Interest:

23.17 m (as of 10/28/08)

Short Int Ratio:

1.20

% of Float:

1.40%

Non-Corp. Insider Hold'gs:

0.10% (as of 9/1/08)

Bought Prev 3 Mo:

Sold Prev 3 Mo:

Institution Hold'gs:

83.10% (as of 10/1/08)

Total Held:

1.35 b

Institutions:

986

Bought Prev Mo:

142.42 m

Sold Prev Mo:

185.98 m